COPENHAGEN, Denmark, Sept. 22, 2022 — The Novo Nordisk Foundation has awarded a grant of US$ 200 million (DKK 1.5 billion) to establish the first full-scale quantum computer for the development of new medicines and provide new insights into climate change and the green transition, which is not possible with classical computers today. The ambitious Novo Nordisk Foundation Quantum Computing Program launched in collaboration with the University of Copenhagen includes world-leading researchers in quantum computing from Denmark, Canada, The Netherlands and the USA.
Quantum computing offers enormous potential but challenges persist in developing a fully scaled, fault-tolerant, generally applicable quantum computer. The program will focus on developing quantum hardware and quantum materials as well as algorithms to deliver a quantum computer that can solve tasks which today are unsolvable by current computers.
“We want to create an international powerhouse in quantum research, a field with tremendous potential. We want to create, mature and develop technology that can solve major and current challenges within health, sustainability and other areas,” said Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation.
Huge Potential in the Life Sciences
A fully functional quantum computer can very rapidly perform complicated calculations that classical computers either cannot or would optimally require several years to perform. A quantum computer therefore creates opportunities for developing new solutions in several areas.
Quantum computers have particularly revolutionary potential in the life sciences. Quantum computers can especially make a difference here because nature has many quantum mechanical systems that cannot currently be classified and properly understood. A quantum computer has an inherent capability to solve such tasks.
“Within the life sciences, for example, we can accelerate development in personalized medicine by letting quantum computers process the enormous amount of data available about the human genome and diseases,” said Lene Oddershede, Senior Vice President, Natural & Technical Sciences, Novo Nordisk. Foundation. “This will make it easier to tailor optimal treatment. In the Quantum Computing Programme, physicists and engineers will work closely with researchers from the life sciences on a daily basis. The development of the technology will be guided by concrete biological experiments and problems, and this close interdisciplinarity is a crucial parameter for success.”
Part of the grant for the Novo Nordisk Foundation Quantum Computing Program is earmarked for establishing Quantum Foundry P/S, a partner company. This company is a fabrication facility that will supply materials and hardware to the researchers in the program and work very closely with the rest of the program.
During the first seven years of the twelve-year collaboration, the researchers and engineers will develop the materials and hardware for the quantum computer. The researchers will establish capabilities to co-engineer three of the most promising quantum computing platforms which will set a basis for determining which platform or parts thereof are most suitable to expand further.
The second half of the project will be spent scaling the selected platform up to a size so that it becomes usable for university and industry researchers in addition to using it to solve relevant problems within the life sciences.
The Novo Nordisk Foundation Program differs significantly from other major, known quantum computing programs in the world.
“The other major initiatives globally have already chosen their platforms and are trying to optimize them. But we predict that many will run into a dead end at a time when there will be fundamental limitations either in the quality of qubits or in terms of scaling up. We will spend seven years identifying the platform that offers the greatest opportunity to build a usable quantum computer,” explained Peter Krogstrup Jeppesen, Professor, Nils Bohr Institute, University of Copenhagen, who is leading the Quantum Computing Programme.
About the Novo Nordisk Foundation
The Novo Nordisk Foundation is an independent Danish foundation with corporate interests. The vision of the Foundation is to contribute significantly to research and development that improves the lives of people and the sustainability of society. Since 2010, the Foundation has donated more than DKK 30 billion (€4 billion), primarily for research at public institutions and hospitals in Denmark and the other Nordic countries as well as research-based treatment and prevention of diabetes.
Source: Novo Nordisk Foundation